Humacyte Inc

NASDAQ:HUMA   3:59:50 PM EDT
10.36
-0.58 (-5.30%)
Earnings Announcements

Humacyte Reports Third Quarter 2021 Financial Results And Provides Business Highlights

Published: 11/12/2021 12:47 GMT
Humacyte Inc (HUMA) - Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights.
Q3 Loss per Share $0.72.
Q3 Earnings per Share View $-0.21 -- Refinitiv Ibes Data (analyst estimates).
Cash and Cash Equivalents to Be Sufficient to Fund Operations at Least Through First Anticipated Approval and Market Launch of Hav.
Revenue is expected to be $0.25 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0.25 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.